Human studies have confirmed 5-HT overactivity, with approximately 25% higher levels in ME/CFS patients under the dl-fenfluramine (an indirect central 5-HT agonist) challenge [55, 56]. The gene discussed is HTR5A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.